Comparison of 18F–FDG PET/MRI and MRI alone for whole-body staging and potential impact on therapeutic management of women with suspected recurrent pelvic cancer: a follow-up study
- 21 November 2017
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 45 (4) , 622-629
Abstract
To evaluate the diagnostic performance of 18F–FDG PET/MRI for whole-body staging and potential changes in therapeutic management of women with suspected recurrent pelvic cancer in comparison with MRI alone.Keywords
This publication has 34 references indexed in Scilit:
- Management of recurrent cervical cancer: A review of the literatureSurgical Oncology, 2012
- The role of FDG-PET/CT in gynaecological cancersCancer Imaging, 2012
- Pelvic exenteration for recurrent cervical cancer: ten-year experience at National Cancer Center in KoreaJournal of Gynecologic Oncology, 2012
- Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortBritish Journal of Cancer, 2011
- Treatment for Advanced and Recurrent Endometrial Carcinoma: Combined ModalitiesThe Oncologist, 2010
- Detection of Recurrence by 18F-FDG PET in Patients with Endometrial Cancer Showing No Evidence of DiseaseJournal of Korean Medical Science, 2010
- Application of 18F-FDG PET/CT in cervical cancer with elevated levels of serum squamous cell carcinoma antigen during the follow-upChinese Journal of Cancer, 2009
- Clinical use of combined positron emission tomography and computed tomography (FDG-PET/CT) in recurrent ovarian cancerGynecologic Oncology, 2007
- Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: From diagnosis to prognosisGynecologic Oncology, 2006
- Patterns of recurrence in patients with squamous cell carcinoma of the vulvaCancer, 2000